Live Breaking News & Updates on விலே ஆரம்ப பார்வை

 E-Mail
The impact of the COVID-19 pandemic on public health is staggering; more than one hundred million cases and two million deaths worldwide. In response, most countries and local governments have taken substantial measures such as travel restrictions and physical distancing to keep their citizens safe. Both the pandemic and related protective measures pose challenges for ongoing clinical research studies seeking to treat and prevent the world s greatest public health emergencies including COVID-19, but also Alzheimer s disease and other dementia.
In a new paper from the World-Wide FINGERS network in Alzheimer s & Dementia: Translational Research and Clinical Interventions, first author Susanne Röhr, Ph.D., clinical psychologist at the Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Germany, and colleagues provide timely guidance on the design and management of clinical research during COVID-19 specifically on the co ....

Hidenori Arai , Mark Espeland , Mariac Carrillo , Miia Kivipelto , National Center , Global Brain Health Institute , Occupational Health , Institute Of Social Medicine , Brain Health , Clinical Geriatrics At Karolinska Institute , Public Health , University Of Leipzig , Alzheimer Association , Translational Research , Medicine At Wake Forest School Of , Translational Research Clinical Interventions , Clinical Interventions , Social Medicine , Atlantic Fellow , Global Brain Health , Internal Medicine , Wake Forest School , Clinical Geriatrics , Karolinska Institute , Analysis Plans , Multidomain Intervention Clinical Trials ,